Results for tag: "Rapivab"

Rapivab is a market of antiviral drugs used to treat infectious diseases. It is composed of drugs that target a variety of viruses, including influenza, respiratory syncytial virus, and herpes simplex virus. These drugs are used to treat a range of symptoms, from mild to severe, and can be administered orally, intravenously, or intramuscularly. Rapivab is a relatively new market, with the first drug approved by the US Food and Drug Administration in 2013. Rapivab drugs are designed to target specific viruses, and are often used in combination with other treatments. They are typically used to reduce the severity of symptoms, shorten the duration of illness, and reduce the risk of complications. They are also used to prevent the spread of infection, and to reduce the risk of transmission to others. Rapivab drugs are available from a variety of pharmaceutical companies, including GlaxoSmithKline, Merck, and Sanofi. These companies produce a range of Rapivab drugs, including Tamiflu, Relenza, and Rapivab. Show Less Read more